缺氧诱导的葡萄糖转运体表达影响肝细胞癌18F-FDG PET-CT显像
该研究探讨肝细胞癌18F-FDG PET-CT检查中标准摄取值(SUV)差异的分子机制,以及缺氧诱导的葡萄糖转运体表达是否参与肝癌进展和糖酵解速率。在细胞水平检测缺氧和常氧条件下GLUT1、GLUT3表达、糖酵解和FDG摄取。结果显示高SUVmax患者GLUT1和GLUT3过表达与高葡萄糖摄取及总生存相关,缺氧可显著诱导肝癌细胞GLUT1和GLUT3表达,高表达与高糖酵解速率和18F-FDG摄取相关。结论认为缺氧诱导的葡萄糖转运体表达可能是18F-FDG PET-CT显像变异及肝细胞癌进展的 contributing 因素。
要点
- 高SUVmax肝细胞癌患者GLUT1和GLUT3过表达与高葡萄糖摄取及总生存相关。
- 缺氧可显著诱导不同肝癌细胞中GLUT1和GLUT3的表达。
- 肝癌细胞GLUT1和GLUT3高表达与高糖酵解速率和18F-FDG摄取相关。
核心结论
- GLUT1和GLUT3过表达显著增加肝细胞癌细胞的葡萄糖摄取。
- 缺氧诱导的葡萄糖转运体表达可能是18F-FDG PET-CT显像变异及肝细胞癌进展的 contributing 因素。
研究设计与样本
- 使用GeneChip Human Genome U133 Plus 2.0 Arrays进行全基因组基因表达谱分析,并用免疫组化验证SUVmax与GLUT1和GLUT3表达的关系。
- 在缺氧和常氧条件下用RT-qPCR监测不同肝癌细胞中GLUT1和GLUT3表达,用Seahorse XF糖酵解压力测试和18F-FDG PET-CT检测糖酵解和FDG摄取。
- 用荧光D-葡萄糖类似物2-NBDG及流式细胞术检测GLUT1和GLUT3对肝癌细胞葡萄糖摄取的影响。
主要发现
- 高SUVmax和低SUVmax肝细胞癌患者样本之间葡萄糖转运体表达存在差异。
- 高SUVmax患者中GLUT1和GLUT3过表达与高葡萄糖摄取及总生存相关。
- 缺氧在不同肝癌细胞中显著诱导GLUT1和GLUT3表达。
- 肝癌细胞中GLUT1和GLUT3高表达与高糖酵解速率和18F-FDG摄取相关。
- 数据提示缺氧诱导的葡萄糖转运体表达可导致18F-FDG PET-CT显像变异和肝细胞癌进展,并与更大肿瘤尺寸、复发和较差生存等更具侵袭性的疾病表型相关。
临床怎么用
- 解读肝细胞癌18F-FDG PET-CT的SUV变异时,可考虑缺氧诱导的GLUT1和GLUT3表达作为潜在分子因素。
- GLUT1和GLUT3表达及缺氧状态可能有助于理解肝癌的糖酵解表型和侵袭性生物学行为。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the molecular mechanisms underlying the variable standard uptake value (SUV) of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET-CT) imaging in hepatocellular carcinoma (HCC) and whether hypoxia-induced glucose transporter expression contributes to the progression of HCC and the rate of glycolysis in HCC cells. MATERIALS AND METHODS: Sixteen HCC specimens obtained from patients who underwent pre-treatment staging with 18F-FDG PET-CT imaging were divided into high maximum SUV (SUVmax > 8) and low SUVmax (SUVmax < 5) groups and employed for whole-genome gene expression profiling using GeneChip Human Genome U133 Plus 2.0 Arrays. The relationship between SUVmax and the expression of glucose transporters 1 and 3 (GLUT1 and GLUT3) was further validated using immunohistochemical analysis. The expression of GLUT1 and GLUT3 in different HCC cells under hypoxia and normoxia conditions were monitored by quantitative reverse transcription PCR (RT-qPCR). Glycolysis and FDG uptake by HCC cells were measured using the Seahorse XF glycolysis stress test and 18F-FDG PET-CT imaging. The effect of GLUT1 and GLUT3 on glucose uptake in HCC cells was examined using the fluorescent D-glucose analog 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-d-glucose (2-NBDG) followed by detection of fluorescence produced by the cells using flow cytometry. RESULTS: Glucose transporters are differentially expressed between samples from HCC patients with high and low SUVmax. In particular, over-expression of GLUT1 and GLUT3 in high SUVmax patients was correlated with high glucose uptake and overall survival. The expression of GLUT1 and GLUT3 was significantly induced by hypoxia in different HCC cells. High expression of GLUT1 and GLUT3 in HCC cells were correlated with high rates of glycolysis and 18F-FDG uptake. Therefore, our data suggested that hypoxia-induced glucose transporters expression could result in the variations of 18F-FDG PET-CT imaging and progression of HCC, contributing to more aggressive disease phenotypes like large tumor size, recurrence, and poor survival. CONCLUSION: Over-expression of GLUT1 and GLUT3 significantly increase glucose uptake in HCC cells. Hypoxia-induced glucose transporters expression may therefore be a contributing variable in 18F-FDG PET-CT imaging and progression in HCC.
引用
- Xia H, Chen J, Gao H, et al. Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2019. PMID: 31832727. doi:10.1007/s00259-019-04638-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。